Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
363 studies found for:    Open Studies | "Multiple Sclerosis"
Show Display Options
Rank Status Study
21 Unknown  Worms for Immune Regulation of Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: Hookworm larvae;   Biological: Placebo
22 Recruiting Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
Condition: Primary Progressive Multiple Sclerosis
Intervention: Other: generation of 'omic markers of disease progression
23 Unknown  Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis
Conditions: Multiple Sclerosis;   Cognitive Impairment
24 Unknown  A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Avonex and Topamax
25 Recruiting EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Interventions: Device: spinal cord MRI follow-up;   Other: clinical follow-up;   Other: brain MRI follow-up
26 Unknown  The Effects of Aerobics Training on Balance in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Other: Non Impact Aerobics;   Other: Passive : lecture series
27 Recruiting Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients With Primary Progressive Multiple Sclerosis (IPPoMS)
Condition: Primary Progressive Multiple Sclerosis
Intervention: Drug: Idebenone
28 Recruiting Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: MD1003 100mg capsule
29 Recruiting A Phase 4 Study to Assess the Impact of Patient Support Program on Health Related Quality of Life and Adherence in Subjects With Relapsing-Remitting Multiple Sclerosis Administered Rebif® With the RebiSmart™ Device
Conditions: Multiple Sclerosis;   Relapsing-Remitting
Interventions: Other: Technical support for the RebiSmart™ device;   Other: Patient support program (MinSupport Plus)
30 Recruiting Biologic Basis for Multiple Sclerosis Disease Progression in RRMS Patients Treated With Gilenya
Condition: Multiple Sclerosis-Relapsing-Remitting
Intervention: Drug: Gilenya
31 Unknown  Lubiprostone in Patients With Multiple Sclerosis Associated Constipation
Conditions: Multiple Sclerosis;   Constipation
Interventions: Drug: Lubiprostone;   Drug: Placebo
32 Unknown  Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Other: Neuropsychological assessment
33 Recruiting A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Rebif®
34 Not yet recruiting A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: NeuroVax;   Biological: IFA Incomplete Freund's Adjuvant
35 Unknown  A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Other: MSDX Complex-1 Biomarker test
36 Not yet recruiting Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
Conditions: Multiple Sclerosis;   Pain;   Depression
Intervention: Behavioral: Collaborative Care (CC)
37 Not yet recruiting Vitamine D in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Vitamin D;   Drug: Placebo
38 Recruiting Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Prednisone;   Drug: Placebo
39 Recruiting Trekking Poles to Aid Multiple Sclerosis Gait Impairment
Condition: Multiple Sclerosis
Interventions: Other: No device;   Device: Single-point cane (SPC);   Device: Four-point cane (FPC);   Device: Trekking pole (TP).
40 Unknown  Cannabis for Spasticity in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Smoked Cannabis;   Drug: Smoked Cannabis and oral marinol;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years